Three separate probes have been launched to determine whether the tragedy was caused by a procedural error or by the substance.

TOP INSIGHT
On behalf of Portuguese pharmaceutical company Bial, the phase I trial for a new pain and mood disorder medication was tested by French laboratory Biotrial.
"A quicker alert would have been appreciated," she said.
"Faced with such a serious situation, we would expect the laboratory to approach the health authorities more quickly."
Six people were hospitalized after taking part in a Phase I trial for a new pain and mood disorder medication being tested by French laboratory Biotrial on behalf of Portuguese pharmaceutical company Bial.
One died on January 17 after being rendered brain dead. The other five, aged 28 to 49, were said to be in a stable condition.
Three separate probes have been launched to determine whether the tragedy was caused by a procedural error or by the substance.
Source-AFP
MEDINDIA


Email









